X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Health and Quality of Life Outcomes

期刊標題檢索 HEALTH QUAL LIF 最新評論: Can be provided to him, with the note not for public disclosure (2024-05-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Health and Quality of Life Outcomes]您好,您是該頁面的第 34299 位訪客。

期刊簡介
期刊名稱Health and Quality of Life Outcomes Health and Quality of Life Outcomes
LetPub Score
5.1
50 ratings
Rate

Reputation
5.8

Influence
4.1

Speed
6.9

期刊簡稱HEALTH QUAL LIFE OUT
ISSN1477-7525
h-index97
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.301.1401.563
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Public Health, Environmental and Occupational Health
Q187 / 665

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Health and Quality of Life Outcomes is an open access, peer-reviewed, journal offering high quality articles, rapid publication and wide diffusion in the public domain.

Health and Quality of Life Outcomes considers original manuscripts on the Health-Related Quality of Life (HRQOL) assessment for evaluation of medical and psychosocial interventions. It also considers approaches and studies on psychometric properties of HRQOL and patient reported outcome measures, including cultural validation of instruments if they provide information about the impact of interventions. The journal publishes study protocols and reviews summarising the present state of knowledge concerning a particular aspect of HRQOL and patient reported outcome measures. Reviews should generally follow systematic review methodology. Comments on articles and letters to the editor are welcome.
官方網站http://hqlo.biomedcentral.com
在線稿件提交https://submission.nature.com/new-submission/12955/3
開放訪問Yes
出版商BioMed Central
主題領域医学
出版國/地區ENGLAND
發行頻率不定期刊行
創刊年2003
每年文章數128每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP2190; USD2990; EUR2490; )
APC waiver:Check Notes
Other charges: No
Keywords: health-related quality of life assessment、evaluation of medical interventions、medical outcomes
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEALTH CARE SCIENCES & SERVICESSCIEQ141/174
HEALTH POLICY & SERVICESSSCIQ125/118
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
Social Science Citation Index
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1477-7525%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Health and Quality of Life Outcomes】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Implementation ScienceH-index: 78

    CiteScore: 14.30
    HEALTH AFFAIRSH-index: 156

    CiteScore: 15.00
    JOURNAL OF MEDICAL INTERNET RESEARCHH-index: 116

    CiteScore: 14.40
    ACADEMIC MEDICINEH-index: 130

    CiteScore: 7.80
    MEDICAL EDUCATIONH-index: 120

    CiteScore: 8.40
    VALUE IN HEALTHH-index: 87

    CiteScore: 6.90
    MILBANK QUARTERLYH-index: 92

    CiteScore: 9.60
    BMC Medical Research MethodologyH-index: 97

    CiteScore: 6.50
    HEALTH POLICYH-index: 79

    CiteScore: 6.40
    HEALTH TECHNOLOGY ASSESSMENTH-index: 110

    CiteScore: 6.90
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF MEDICAL INTERNET RESEARCH109859
    JOURNAL OF MEDICAL SYSTEMS81241
    BMC HEALTH SERVICES RESEARCH48116
    VALUE IN HEALTH40258
    ACADEMIC MEDICINE35026
    MEDICAL EDUCATION30521
    HEALTH AFFAIRS29788
    BMC Medical Research Methodology27770
    JOURNAL OF HEALTH ECONOMICS27726
    HEALTH ECONOMICS26572
  •  

    Health and Quality of Life Outcomes Health and Quality of Life Outcomes
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Health and Quality of Life Outcomes] 的評論撰寫評論
作者: 云来银磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-28 23:28:05 評論於
Can be provided to him, with the note not for public disclosure
(0) 讚! | 云来银磊

作者: 幽香雅丹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-26 15:29:19 評論於
Can you provide the raw data? Some of the data may involve confidentiality
(0) 讚! | 幽香雅丹

作者: 云居宏胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-07 23:47:22 評論於
Review speed: 2.0 | Submission success rate: 50.0 Emphasized research areas: quality of life; health economics; disease-related experiences: Within 2 months from submission to rejection, 3 reviewers and 1 editor all provided very constructive feedback, which I accepted carefully
(0) 讚! | 云居宏胜

作者: taoran


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-06 23:55:52 評論於
It is becoming more and more difficult to express opinions.
(2) 讚! | taoran

作者: 风啸哲妍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-27 13:27:36 評論於
Hello, have you received a reply? How long does it usually take for you to receive a reply? It has been over three months since I submitted my application, and I have not heard anything yet
(0) 讚! | 风啸哲妍

作者: 雾都英卫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-10 17:39:53 評論於
Where can I find information about the progress of my submission? It's been two and a half months and there's still no editor appointed. Is this normal?
(0) 讚! | 雾都英卫

作者: 雾都英卫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-02 13:12:21 評論於
May I ask where I can find out about the progress of my submission? It has been a month and a half and I still have not been assigned an editor. Is this normal?
(0) 讚! | 雾都英卫

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:29:48 評論於
Yes
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:15:42 評論於
The number of corresponding authors for SCI journal papers is not necessarily limited to one, and there is no fixed standard for the specific number. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if the paper lists multiple corresponding authors, the first corresponding author will automatically be selected. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements; the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who made the greatest contribution to the experiment and writing of the paper, and is the person whose name appears first in the list of authors. However, in collaborative work, it is common to have joint first authors. There is no clear regulation on the number of joint first authors, and it depends largely on factors such as the workload, length of the paper, the regulations of the publication, and the recognition of the institution. Generally, it is most common for an SCI paper to have 2-4 first authors
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:51:46 評論於
Will all authors receive an email after the article is accepted?
(0) 讚! | 陶宜三岁啦

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-25 09:43:38 評論於
How many corresponding authors/first authors can a journal have?
(0) 讚! | 上清雨真

作者: 蓉沼雯华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-25 16:58:26 評論於
Hello, is the initial review also slow? I see it says it takes three months to make the first decision, which is slower than domestic journals
(0) 讚! | 蓉沼雯华

作者: 蓉沼雯华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-24 10:40:01 評論於
Hello, may I ask how long the initial review usually takes? I've been waiting for three months since the journal mentioned "first decision." That's really slow, to be honest
(0) 讚! | 蓉沼雯华

作者: 宗室羽铮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-23 18:48:59 評論於
Review speed: 2.0 | Submission success rate: 95.0
Preferred research direction: Nursing experience sharing: None
(0) 讚! | 宗室羽铮

作者: Andrea Brook


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-16 14:40:45 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 25.0
Experience Sharing: After being rejected three times after revisions, it feels like some experts' opinions are impossible to change. This is my first time writing for SCI, so I will continue to work hard and hopefully have a successful submission next time
(0) 讚! | Andrea Brook

作者: 月河长钰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-03 21:57:26 評論於
I submitted my paper on 2019.12.24, and it has been revised twice. The third revision on 2020.4.14 was a minor revision. When do you think the acceptance decision will be made?
(0) 讚! | 月河长钰

作者: 月河长钰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-03 16:42:10 評論於
I am currently in minor revision. How much longer do you think it will take for acceptance? I submitted on December 24, 2019, and have already gone through two major revisions. This is the third modification
(0) 讚! | 月河长钰

作者: 月河长钰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-01 16:14:31 評論於
Submitted on 12.24, there have been two revisions, and now it is the third revision, which is a minor one. How much longer do you think it will take?
(0) 讚! | 月河长钰

作者: 孤云星宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-12 17:45:05 評論於
Review speed: 12.0 | Submission acceptance rate: 50.0
Experience sharing: The review process was very slow, with no review fee involved. I submitted in April 2018 and received feedback from the first reviewer in October 2018. I communicated with the editor throughout this period, who was very friendly. I then waited for feedback from the second reviewer, and in March 2019, I received their feedback. After making the necessary revisions, the article was accepted within a week. The publication fee in China was over 14,000. This was my first SCI article, and I believe the wait was worth it
(0) 讚! | 孤云星宇

作者: 稻妻利娇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-23 10:12:16 評論於
No review fee, but very slow
(0) 讚! | 稻妻利娇

作者: 鸣玉桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-02-02 17:25:19 評論於
Review speed: 12.0 Experience sharing: The review process is very slow
(0) 讚! | 鸣玉桑

作者: 深渊洛灵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-02 18:13:56 評論於
Do you want to ask for a review fee? The Little Prince 2017-11-01 19:04:00 posted: Super slow, 7 months, maybe Scandinavians are slower in pace
(0) 讚! | 深渊洛灵

作者: 东京雅霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-01 13:22:40 評論於
Review speed: 6.0 | Submission acceptance rate: 75.0
Experience sharing: Super slow, 7 months, maybe Nordic people are slower paced
(0) 讚! | 东京雅霜

作者: 黑山以菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-10-11 15:00:16 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Experience sharing: The review process is very strict, and the reviewers' questions are very professional and sometimes even require original data. You must answer sincerely and patiently
(0) 讚! | 黑山以菡

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Health and Quality of Life Outcomes] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*